CDC25C is part of the commonly deleted region in 5q-syndrome, and effective treatment of 5q- syndrome with lenalidomide requires haploinsufficiency of CDC25C [48–52]. Here, CDC25C is linked to myelodysplastic syndrome associated with isolated del(5q).